Robert Thomas Dewar

Robert Dewar practices at Healthtexas Provider Network in Dallas, Texas.

Robert Dewar's NPI, 1235592429, was assigned on April 4, 2016. Robert Dewar graduated from McGovern Medical School in 2016. Robert Dewar's New York license number on file is 293589.

Robert Dewar's primary practice is Healthtexas Provider Network, at 301 N Washington Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-3466.

Robert Dewar's primary practice is Healthtexas Provider Network in Dallas, Texas. Robert Dewar is also affiliated with Baylor University Medical Center. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Robert Dewar to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Robert Dewar practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Robert Dewar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Robert Dewar is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Robert Dewar's licenses on file in 3 states: New York, Florida and Texas.

Dmand AI lists acid reflux, acne, acute skin infection, ADHD, alzheimer's disease, aneurysm, aortic atherosclerois and asthma among the conditions Robert Dewar treats.

CMS data shows 1,196 Medicare services from Robert Dewar across 12 procedure codes in 2024, for 209 Medicare patients. Medicare paid $69,449 for them. Every service was in an office.

CMS counts 209 Medicare patients who saw Robert Dewar in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Robert Dewar's median patient age at 61, with 35% women.

In 2024, Robert Dewar wrote 4,929 Medicare Part D claims for 372 patients. 88% of them were for generic drugs. CMS names the drug for 4,255 of them, across 101 drugs with 11 or more claims each, at $418,708 in total drug cost. In 2023, CMS named 4,275 claims across 104 drugs.

Robert Dewar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Robert Dewar as offering telehealth.

CMS Open Payments shows 72 general payments to Robert Dewar from 16 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $585.

Robert Dewar graduated from McGovern Medical School in 2016.

Robert Dewar is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.